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Introduction
Genetic factors influence vulnerability to depression 
(Sullivan et al, 2000), but no specific genes have been de-
finitively implicated. One promising approach is to deter-
mine whether variations in specific (candidate) genes are 
associated not with disease per se, but with traits, such as 
personality factors, that are themselves associated with 
risk for the disorder (Lander and Schork, 1994; Stolten-
berg and Burmeister, 2000). Often such traits have a higher 
heritability than the disease status (Almasy and Blangero, 
2001). Neuroticism, as measured by the NEO personality 
inventory (NEO-PI) (Costa and McCrae, 1997), a psycho-
metrically sound and widely used instrument, is one such 
trait. High scorers on the Neuroticism domain are char-
acterized by frequent experience of “negative emotional-
ity” such as anxiety, low mood, and hostility. Converging 
lines of evidence point to brain-derived neurotrophic fac-
tor (BDNF) as a factor in the pathophysiology of depres-
sion. To explore the possibility that variation in the BDNF 
gene is, in part, responsible for the population variation in 
Neuroticism, we studied a community sample of 441 sub-
jects, genotyping a G→A single-nucleotide polymorphism 
(SNP) responsible for a valine→methionine substitution in 
the prodomain of BDNF. The less common, nonconserved 
Met allele was associated with significantly lower mean 
Neuroticism scores (p = 0.0057). Our study provides fur-
ther evidence and one possible mechanism linking BDNF 
to depression.
BDNF influences neuronal differentiation in devel-
opment, as well as synaptic plasticity and neuronal sur-
vival in adulthood (Thoenen, 1995). Several results suggest 
that it may play a role in the pathophysiology of depres-
sion (Duman, 2002). Heterozygous BDNF knockout mice 
show behavioral abnormalities consistent with serotoner-
gic dysfunction. These behavioral changes are corrected 
through antidepressant treatment (Lyons et al, 1999). Ad-
ditional evidence connecting BDNF and depression comes 
from studies showing that infusion of recombinant BDNF 
into the mouse midbrain (Siuciak et al, 1997) or hippocam-
pus (Duman, 2002) produces an antidepressant effect in 
both learned helplessness and forced swim models of de-
pression. Furthermore, stress, a trigger for depression, low-
ers hippocampal transcription of BDNF in mice (Nibuya 
et al, 1995). In contrast, numerous antidepressants, includ-
ing selective serotonin reuptake inhibitors, electroconvul-
sive therapy, lithium, and monoamine oxidase inhibitors 
(Nibuya et al, 1995; Russo-Neustadt et al, 1999), increase 
BDNF transcription. This transcriptional increase occurs af-
ter a delay similar to that seen in the onset of clinical effects 
of antidepressants (Nibuya et al, 1995).
The recent finding that there is significant neurogenesis 
in the hippocampi of adult primates suggests a mechanism 
through which BDNF might relate to depression (Gould et 
al, 1999). The hippocampi of depressed patients are signif-
icantly smaller than those of healthy individuals (Sheline, 
2000). This reduced volume may be the result of decreased 
neurogenesis in depressed individuals, a possibility sup-
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ported by the findings that hippocampal neurogenesis is 
reduced by stress (Gould et al, 1998) and increased by an-
tidepressant treatment (Malberg et al, 2000). The parallel 
changes in BDNF levels and neurogenesis in response to 
stress and antidepressant treatment suggest a connection 
between BDNF and hippocampal neurogenesis. Together, 
these lines of evidence lead to the neurotrophic hypothesis 
of depression (Duman et al, 1997), suggesting that genetic 
variations in BDNF might influence hippocampal neuro-
genesis and ultimately vulnerability to depression.
Neuroticism is a strong marker for vulnerability to de-
pression (Duggan et al, 1995; Kendler et al, 1993). Character-
istics of Neuroticism make it particularly useful for genetic 
studies of depression. The reported heritability of Neurot-
icism is 40–50% (Jang et al, 1996; Lake et al, 2000), equal to 
or greater than heritibility estimates for depression (36%) 
(Kendler and Prescott, 1999). Furthermore, approximately 
70% of the correlation between Neuroticism and depres-
sion risk is because of shared genetic risk factors (Kendler 
et al, 1993). Neuroticism is also a quantitative trait and sta-
ble through adulthood (Costa and McCrae, 1988). In this 
study, we explore whether a BDNF variant is associated 
with variation in Neuroticism.
Methods
Subjects
The subjects, 268 female and 173 male, were from 257 
families participating in the Family Blood Pressure Pro-
gram at the Tecumseh, Michigan Site (Boerwinkle, 2002). 
In all, 99% of the subjects were non-Hispanic Caucasians. 
Family eligibility in this study was dependent on the avail-
ability of a proband between 25 and 40 years old with a 
systolic blood pressure in the upper 15% of blood pressure 
distribution in earlier rounds of examination. Parents and 
siblings of probands were studied when available.
Genotyping
In Genbank sequences and the public SNP database ( 
http://www.ncbi.nlm.nih.gov/ ), we identified a common 
coding variant in the BDNF gene, a G→A polymorphism 
responsible for a Val66Met change (Cargill et al, 1999). Elec-
tronic restriction mapping showed that the “A” allele cre-
ates a restriction site for the enzyme Hsp92II. We designed 
primers (SBDNF1-AAA GAA GCA AAC ATC CGA GGA 
CAA G; SBDNF2-ATT CCT CCA GCA GAA AGA GAA 
GAG G) resulting in a 274 bp PCR product. A PTC 100 
thermal cycler (MJ Research, Watertown, MA, USA) was 
used for DNA amplification. Amplification reactions were 
performed in a total volume of 20 μl, containing approxi-
mately 50 ng of genomic template, 1 μM of each primer, 
200 μM dNTP, 2 μl 10X Opti-Prime Buffer 6 (Stratagene, 
La Jolla, CA, USA) and 1 U of Taq polymerase. The PCR 
cycling conditions consisted of an initial denaturation for 
2 min at 94°C followed by 35 cycles of 94°C for 1 min, 55°C 
for 2 min, and 72 for 2 min and a final extension at 72°C for 
4 min. In the presence of the “G” allele, Hsp92II digestion 
produced two products, 57 and 217 bp, whereas the “A” al-
lele produced 3 products, 57, 77, and 140 bp. The presence 
of a second Hsp92II site served as a restriction digest con-
trol, identifying incomplete digests for repeat analysis. PCR 
products were electrophoresed on a 2% agarose gel and vi-
sualized using the Gel-Star nucleic acid gel stain (BioWhit-
taker Molecular Applications, Rockland, ME, USA). Of all 
subjects, 91% were successfully genotyped.
Personality Inventory
The NEO-PI was administered to the subjects in the 
study. This inventory, consisting of 181 questions, as-
sesses subjects on five global personality domains and 
breaks down three of these domains into six specific facets 
each. The NEO-PI is a well-established inventory designed 
through factor analytic strategies. The inventory provides 
high test–retest reliability and longitudinal stability (Costa 
and McCrae, 1997).
Statistical Analysis
The presence of association was determined using the 
QTDT Program version 2.1 (available at http://www.sph.
umich.edu/statgen/abecasis/QTDT/ ). QTDT was used to 
fit a variance components model to account for familial re-
semblance because of kinship and linkage. However, rather 
than modeling allelic effects based on allelic transmission, 
we tested the overall additive genetic effect of each poly-
morphism (Abecasis et al, 2000a, 2000b).
Results
We analyzed DNA samples from 441 subjects in the 
Tecumseh, Michigan Blood Pressure Study (Boerwinkle, 
2002) at a G→A polymorphism responsible for a Val66Met 
change (Cargill et al, 1999) in the prodomain of the BDNF 
gene. The frequency of the alleles (adjusted for familial cor-
relations) were: Val = 0.75, Met = 0.25, similar to previously 
reported frequencies (Val = 0.68 and 0.83, Met = 0.32 and 
0.17) (Cargill et al, 1999; Sklar, in press). In this sample there 
was no significant correlation between blood pressure and 
Neuroticism (diastolic blood pressure r = –0.064, p = 0.116; 
systolic blood pressure r = -0.016, p = 0.696). Since the mean 
Neuroticism score for the heterozygous Val/Met group was 
intermediate to the two homozygous groups, an additive 
model of genotype effect was used. In an analysis control-
ling for familial correlations, the Met allele showed a signif-
icant association with lower mean Neuroticism scores (p = 
0.0057; Figure 1). No personality domain, other than Neu-
roticism, was associated with BDNF genotype (Table 1). Of 
the six Neuroticism facets, only depression (N3), self-con-
sciousness (N4), anxiety (N1), and vulnerability (N6) were 
associated with BDNF genotype. Of the 12 facets compris-
ing the other personality domains, only the openness facet, 
feelings (O3) was associated with BDNF genotype (Table 
2). This association was modest. For all but one of the as-
sociated facets, the heterozygous Val/Met group score was 
intermediate to the two homozygous groups, supporting 
an additive model for genotype effect. For the O3 facet, the 
heterozygous Val/Met group score was similar to the Met/
Met group score, supporting a model where the Met allele 
may have a dominant effect.
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A concern for this type of study is the potential pres-
ence of population stratification resulting in the appear-
ance of false associations (Lander and Schork, 1994). To 
assess if the reported results were because of stratifica-
tion, STRUCTURE, a program designed to infer popu-
lation structure utilizing genotypes from numerous un-
linked markers as genomic controls, was implemented 
(Pritchard and Rosenberg, 1999). Weak evidence for clus-
tering into two groups was found (p = 0.02) (Theil and 
Schork, personal communication; data available upon 
request). There were no significant differences in either 
BDNF allele frequency or any of the personality traits be-
tween the two clusters. Furthermore, the population clus-
ter that was nonsignificantly higher for mean Neuroticism 
scores had a nonsignificantly greater Met allele frequency. 
Thus, these reported results are unlikely to be the prod-
uct of population stratification (data available on request). 
An additional concern for this study is that the popula-
tion sample studied was chosen through the presence of 
a moderately hypertensive proband. Although there is no 
association in this sample between blood pressure and ei-
ther BDNF or Neuroticism, the hypertensive nature of the 
sample should be noted. Lastly, we have demonstrated a 
role for this BDNF variant in personality variation in a ru-
ral Michigan, non-Hispanic Caucasian sample, but its role 
in other populations is not known.
Discussion
Our results indicate that this BDNF polymorphism may 
account for a small, but significant proportion of the popu-
lation variation in Neuroticism. This variant explains about 
4% of the genetic variance in our sample. There are several 
reasons to think that these results for Neuroticism are rele-
vant to depression. First, Neuroticism is strongly associated 
with depression (Duggan et al, 1995; Kendler et al, 1993). 
This established association between Neuroticism and de-
pression is mediated entirely by four of the six Neuroticism 
facets: anxiety (N1), depression (N3), self-consciousness 
(N4), and vulnerability (N6) (Bagby et al, 1996). These four 
facets are precisely those that associate with BDNF geno-
type in the Tecumseh sample. The other two Neuroticism 
facets, hostility (N2) and impulsiveness (N5), are not asso-
ciated with depression and show no association with BDNF 
in this study ( Table 2). Outside of the Neuroticism domain, 
the facets that have been associated with depression are 
Figure 1. NEO-PI neuroticism scores as a function of BDNF genotype.
Table 2. NEO-PI facet scoresa as a function of BDNF genotype in 
Tecumseh population
Facet                           BDNF genotype  N        Mean       SEM     p value
N1—anxiety Val/Val 258 15.83 0.31 0.0020
  Val/Met 161 14.94 0.38  
  Met/Met 20 13.52 1.02  
           
N2—hostility Val/Val 258 12.18 0.28 0.597
  Val/Met 161 11.98 0.37  
  Met/Met 20 11.77 0.82  
           
N3—depression Val/Val 255 14.39 0.34 0.0058
  Val/Met 161 13.34 0.46  
  Met/Met 20 11.39 1.04  
           
N4—self-consciousness Val/Val 258 15.74 15.74 0.0086
  Val/Met 161 14.86 14.86  
  Met/Met 20 13.05 13.05  
           
N5—impulsiveness Val/Val 258 16.72 0.23 0.497
  Val/Met 161 16.91 0.31  
  Met/Met 20 15.15 1.13  
           
N6—vulnerability Val/Val 259 11.41 0.23 0.0390
  Val/Met 162 11.08 0.34  
  Met/Met 20 9.00 0.70  
           
O3—feelings Val/Val 254 20.90 0.24 0.0215
  Val/Met 161 19.78 0.28  
  Met/Met 20 19.92 0.83  
a All six Neuroticism facets are shown along with O3, the only facet 
from the other domains that reached nominal significance.
Table 1. NEO-PI domain scores as a function of BDNF genotype
Domain              BDNF genotype       N          Mean         SEM      p value
Neuroticism Val/Val 255 86.35 1.27 0.0057
  Val/Met 161 83.11 1.67  
  Met/Met 20 73.90 3.66  
           
Extraversion Val/Val 255 107.22 1.07 0.329
  Val/Met 162 108.17 1.40  
  Met/Met 20 111.18 2.76  
           
Openness Val/Val 254 104.19 1.07 0.197
  Val/Met 160 101.90 1.23  
  Met/Met 20 102.18 3.69  
           
Conscientiousness Val/Val 258 48.10 0.50 0.736
  Val/Met 161 47.53 0.66  
  Met/Met 20 48.53 1.95  
           
Agreeableness Val/Val 259 47.19 0.40 0.721
  Val/Met 162 47.21 0.55  
  Met/Met 20 48.05 1.94  
400  Se n et a l.  i n Ne ur op s y c h op ha r ma c o l og y  28 (2003)
aesthetics (O2) and feelings (O3) (Bagby et al, 1996; Wolfen-
stein and Trull, 1997). In our sample, the feelings (O3) facet 
is significantly associated with BDNF while aesthetics (O2) 
shows a trend towards an association (p < 0.10). The re-
ported p values were not corrected for multiple testing. 
However, when the BDNF association with Neuroticism is 
corrected for the 5 NEO-PI domains, the results remain sig-
nificant. This is conservative since we went into this study 
with an a priori hypothesis that BDNF may be a candidate 
gene for Neuroticism, not the other domains. Since the fac-
ets are strongly associated with each other, it is difficult to 
assess how to correct for further multiple testing.
Further evidence that the Val allele might increase the 
risk of depression comes from a study showing that this Val 
allele was preferentially transmitted to bipolar probands in 
families (Sklar, in press). The finding that the Val allele is as-
sociated with the risk of clinical bipolar disorder supports 
our findings that the same allele is associated with increased 
scores on personality facets associated with depression in a 
community sample. While the effect size of this BDNF vari-
ant for Neuroticism is not large, the effect is in the same di-
rection as in bipolar disorder and of the magnitude expected 
for an intermediate phenotype in a polygenic trait.
The functional significance of this Val→Met substitution, 
if any, is unknown. Protein sequence comparisons (data not 
shown) reveal that the common Val allele is completely con-
served among  > 70 species including mammals, birds and 
fish (Murphy et al, 2001). That is, the “protective” Met allele 
appears to be novel in evolutionary history. Our results, to-
gether with the neurotrophic hypothesis of depression (Du-
man et al, 1997), predict that the Met allele of BDNF pro-
duces higher activity or more efficient processing of BDNF. 
Given the proximity of this variant to a BDNF cleavage site, 
it is possible that this variant affects the efficiency of cleav-
age at this site (Mowla et al, 2001). The variant may also be 
involved in determining the efficiency of mature BDNF fold-
ing. Alternatively, the variant may have no functional conse-
quence, but be in linkage disequilibrium with a nearby func-
tional polymorphism. These models can be tested in vitro or 
in animal models. Given the increase of BDNF transcription 
in response to antidepressant treatment, further work is also 
indicated to determine if this genetic variation predicts clini-
cal response to specific antidepressants.
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